Diclofenac Diethylamine, Methyl Salicylate, Linseed Oil, and Menthol Gel for the local symptomatic relief of pain and inflammation in:
Trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises.
Localized forms of soft tissue rheumatism
It is recommended that the treatment be reviewed after 14 days in these indications.
For the treatment of osteoarthritis of superficial joints such as the knee and those of hands. In the treatment of osteoarthritis, therapy should be reviewed after 4 weeks.
The possibility of systemic adverse events from application of Lonac-D gel cannot be excluded if the preparation is used on large areas of skin and over a prolonged period (see the product information on systemic forms of diclofenac).
Concomitant use of oral NSAIDs should be cautioned, as the incidence of untoward effects, particularly systemic side effects, may increase.
Lonac-D gel should not be co-administered with other products containing diclofenac.
Lonac-D gel should be applied only to intact, non-diseased skin and not to skin wounds or open injuries. It should not be allowed to come into contact with the eyes or mucous membranes and should not be ingested.
Discontinue the treatment if a skin rash develops after applying the product.
Lonac-D gel can be used with non-occlusive bandages but should not be used with an airtight occlusive dressing.
Some possibility of gastrointestinal bleeding in those with a significant history of this condition has been reported in isolated cases.
Adults: Diclofenac Diethylamine, Methyl Salicylate, Linseed Oil, and Menthol Gel should be rubbed gently into the skin. Depending on the size of the affected site to be treated, 2-4 g (a circular-shaped mass approximately 2.0-2.5 cm in diameter) should be applied 3-4 times daily.
After application, the hands should be washed unless they are the site being treated.
Use in the elderly: The usual adult dosage may be used.
Children and adolescents: There are insufficient data on efficacy and safety available for the children and adolescents below 14 years of age. In children aged 14 years and over, if this product is required for more than 7 days for pain relief or if the symptoms worsen, the patient/parents of the adolescent is/are advised to consult a doctor.
Rash, eczema, erythema, dermatitis (including dermatitis contact), pruritus
Store below 30°C, preferably in a cool and dry place. Protect from light.
Keep the medicine out of reach of children.
Lami tube with a white cap containing 15 g of gel. Such a 01 tube in a unit carton with a pack insert.
Contact us directly to receive full information on the product, the formulation, the science behind it, stability data, and more. Our Business Development Manager is a click away.
Questions are useful tools, they open lines of communication; give us information; improve interactions, facilitate analysis, and many more.
A pharma CMO is a special kind of an organization, offering contract manufacturing services to pharmaceutical companies for various kinds of drug formulations.
Reduce overall costs and time to market :
Contract manufacturers already have the needed infrastructure and technical staff, so working with a CMO or CDMO can decrease the cost of manufacturing your pharmaceutical products.
Scalability and flexible production capacity :
You can produce what you need when you need it without worrying about excess capacity. Additionally, CMOs understand the importance of quality and compliance, so you don't have to sacrifice safety for scalability.
Save on upgrading and maintaining equipment :
If you have your manufacturing facility, you’ll have to pay to upgrade your equipment as technology advances—which can get expensive. A CMO/CDMO’s only function is to make and distribute products, so part of their core business responsibility is to update their equipment whenever needed and perform maintenance.
Ease supply chain issues :
During the pandemic, there were several instances of supply chain issues, including medicine shortages. CMOs are generally better equipped than startups to handle a supply chain crisis.
Bandwidth to focus on core competencies
When your company resources aren’t directly allocated to manufacturing and distribution, you have more time to focus on other tasks, like marketing your new drug, researching, or working on drug discovery.
We have 7+ manufacturing sites with a minimum of WHO GMP certification and other country-specific approvals like NAFDAC approved, PPK Kenya Approved, TFDA Tanzania Approved, EU-GMP Approved.
We have below manufacturing capacity:
For Tablet, Capsule, and soft gel: up to 1 million units per shift
For Syrup: up to 0.05 Million per shift
For Ampoule and Vial: up to 0.1 million units per shift
For Ointment and Cream: up to 0.1 million units per shift
For Suppository: 0.1 Million units per shift
